Staging laparotomy in the management of hodgkin's disease: Is it still necessary?

Oncologist

Volumn 1, Issue 1-2, 1996, Pages 41-55

  Multani, Pratik S ^a   Grossbard, Michael L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Hodgkin's disease; Laparotomy; Radiation therapy; Splenectomy; Staging

Indexed keywords

EID: 0002207557     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.1-1-41     Document Type: Article

References (23)

1. Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med 1992;326:678-687.
2. DeVita VT Jr, Hubbard SM. Hodgkin's disease. N Engl J Med 1993;328:560-565.
3. Wingo PA, Tong T, Beiden S. Cancer statistics, 1995. CA 1995;45:8-30.
4. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Medico-Chirugical Transactions 1832;17:68-114.
5. Mauch PM, Kalish LA, Kadin M et al. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer 1993;71:2062-2071.
6. Mauch PM. Controversies in the management of early stage Hodgkin's disease. Blood 1994;83:318-329.
7. Mai DH, Peschel RE, Portlock C et al. Stage I and II subdiaphragmatic Hodgkin's disease. Cancer 1991;68:1476-1481.
8. Leibenhaut MH, Hoppe RT, Varghese A et al. Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients. J Clin Oncol 1987;5:1050-1055.
9. Glatstein E, Guernsey JM, Rosenberg SA et al. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 1969;24:709-718.
10. Piro AJ, Hellman S, Moloney WC. The influence of laparotomy on management decisions in Hodgkin's disease. Arch Intern Med 1972;130:844-848.
11. Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971:31:1860-1861.
12. Lister TA, Crowther D, Sutcliffe SB et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting [published erratum appears in J Clin Oncol 1990;8:1602]. J Clin Oncol 1989:7:1630-1636.
13. Lister TA, Crowther D. Staging for Hodgkin's disease. Semin Oncol 1990:17:696-703.
14. Tubiana M, Henry-Amar M, Carde P et al. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 1989;73:47-56.
15. Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1992;10:210-218.
16. Cimino G, Biti GP, Cartoni C et al. Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy. Eur J Cancer 1992;28A:1853-1855.
17. Zittoun R, Audebert A, Hoerni B et al. Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. J Clin Oncol 1985;3:207-214.
18. Hagemeister FB, Fesus SM, Lamki LM et al. Role of the gallium scan in Hodgkin's disease. Cancer 1990;65:1090-1096.
19. Jochelson MS, Herman TS, Stomper PC et al. Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy. Am J Roentgenol 1988;151:1229-1231.
20. Rostock RA, Siegelman SS, Lenhard RE et al. Thoracic CT scanning for mediastinal Hodgkin's disease: results and therapeutic implications. Int J Rad Oncol Biol Phys 1983;9:1451-1457.
21. Rostock RA, Giangreco A, Wharam MD et al. CT scan modification in the treatment of mediastinal Hodgkin's disease. Cancer 1982;49:2267-2275.
22. Hoppe RT. The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation. Int J Rad Oncol Biol Phys 1985;11:349-355.
23. Radford JA, Cowan RA, Flanagan M et al. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 1988;6:940-946.